The Vexing Problem of Vasoplegia SCOTT SILVESTRY MD FLORIDA HOSPITAL TRANSPLANT INSTITUTE.
-
Upload
samuel-may -
Category
Documents
-
view
212 -
download
0
Transcript of The Vexing Problem of Vasoplegia SCOTT SILVESTRY MD FLORIDA HOSPITAL TRANSPLANT INSTITUTE.
![Page 1: The Vexing Problem of Vasoplegia SCOTT SILVESTRY MD FLORIDA HOSPITAL TRANSPLANT INSTITUTE.](https://reader038.fdocuments.in/reader038/viewer/2022110400/56649daa5503460f94a98619/html5/thumbnails/1.jpg)
The Vexing Problem of VasoplegiaSCOTT SILVESTRY MD
FLORIDA HOSPITAL TRANSPLANT INSTITUTE
![Page 2: The Vexing Problem of Vasoplegia SCOTT SILVESTRY MD FLORIDA HOSPITAL TRANSPLANT INSTITUTE.](https://reader038.fdocuments.in/reader038/viewer/2022110400/56649daa5503460f94a98619/html5/thumbnails/2.jpg)
No relevant disclosures
![Page 3: The Vexing Problem of Vasoplegia SCOTT SILVESTRY MD FLORIDA HOSPITAL TRANSPLANT INSTITUTE.](https://reader038.fdocuments.in/reader038/viewer/2022110400/56649daa5503460f94a98619/html5/thumbnails/3.jpg)
Unexpected refractory hypotension from a severe SIRS response following cardiac surgery involving cardiopulmonary bypass (CPB)
The incidence of VS in cardiac surgical patients is 8% to 10 %, but may increase to upwards of 50% of patients taking renin-angiotensin system (RAS) antagonists.
Vasoplegia
![Page 4: The Vexing Problem of Vasoplegia SCOTT SILVESTRY MD FLORIDA HOSPITAL TRANSPLANT INSTITUTE.](https://reader038.fdocuments.in/reader038/viewer/2022110400/56649daa5503460f94a98619/html5/thumbnails/4.jpg)
No Standard Definition
Form of vasodilitory shock that occurs in the early postoperative period (< 6 hours after weaning from CBP), manifested by:
Hypotension [MAP < 70 without vasoactive agents]
Tachycardia
Normal or increased cardiac output [CI > 2.5 L / min / m2]
Low systemic vascular resistance [SVR < 800 dynes-s · cm−5 · m−2 ]
![Page 5: The Vexing Problem of Vasoplegia SCOTT SILVESTRY MD FLORIDA HOSPITAL TRANSPLANT INSTITUTE.](https://reader038.fdocuments.in/reader038/viewer/2022110400/56649daa5503460f94a98619/html5/thumbnails/5.jpg)
Vasoplegia SyndromePts have poor prognosis,
Especially norepinephrine-resistant vasoplegia.
Catecholamine resistant vasoplegia lasting for more than 36 to 48 hours has a mortality rate as high as 25%.
Associated with longer hospital stays, prolonged ICU stays, prolonged mechanical ventilation and more sternal infections
![Page 6: The Vexing Problem of Vasoplegia SCOTT SILVESTRY MD FLORIDA HOSPITAL TRANSPLANT INSTITUTE.](https://reader038.fdocuments.in/reader038/viewer/2022110400/56649daa5503460f94a98619/html5/thumbnails/6.jpg)
![Page 7: The Vexing Problem of Vasoplegia SCOTT SILVESTRY MD FLORIDA HOSPITAL TRANSPLANT INSTITUTE.](https://reader038.fdocuments.in/reader038/viewer/2022110400/56649daa5503460f94a98619/html5/thumbnails/7.jpg)
![Page 8: The Vexing Problem of Vasoplegia SCOTT SILVESTRY MD FLORIDA HOSPITAL TRANSPLANT INSTITUTE.](https://reader038.fdocuments.in/reader038/viewer/2022110400/56649daa5503460f94a98619/html5/thumbnails/8.jpg)
![Page 9: The Vexing Problem of Vasoplegia SCOTT SILVESTRY MD FLORIDA HOSPITAL TRANSPLANT INSTITUTE.](https://reader038.fdocuments.in/reader038/viewer/2022110400/56649daa5503460f94a98619/html5/thumbnails/9.jpg)
![Page 10: The Vexing Problem of Vasoplegia SCOTT SILVESTRY MD FLORIDA HOSPITAL TRANSPLANT INSTITUTE.](https://reader038.fdocuments.in/reader038/viewer/2022110400/56649daa5503460f94a98619/html5/thumbnails/10.jpg)
![Page 11: The Vexing Problem of Vasoplegia SCOTT SILVESTRY MD FLORIDA HOSPITAL TRANSPLANT INSTITUTE.](https://reader038.fdocuments.in/reader038/viewer/2022110400/56649daa5503460f94a98619/html5/thumbnails/11.jpg)
![Page 12: The Vexing Problem of Vasoplegia SCOTT SILVESTRY MD FLORIDA HOSPITAL TRANSPLANT INSTITUTE.](https://reader038.fdocuments.in/reader038/viewer/2022110400/56649daa5503460f94a98619/html5/thumbnails/12.jpg)
![Page 13: The Vexing Problem of Vasoplegia SCOTT SILVESTRY MD FLORIDA HOSPITAL TRANSPLANT INSTITUTE.](https://reader038.fdocuments.in/reader038/viewer/2022110400/56649daa5503460f94a98619/html5/thumbnails/13.jpg)
![Page 14: The Vexing Problem of Vasoplegia SCOTT SILVESTRY MD FLORIDA HOSPITAL TRANSPLANT INSTITUTE.](https://reader038.fdocuments.in/reader038/viewer/2022110400/56649daa5503460f94a98619/html5/thumbnails/14.jpg)
![Page 15: The Vexing Problem of Vasoplegia SCOTT SILVESTRY MD FLORIDA HOSPITAL TRANSPLANT INSTITUTE.](https://reader038.fdocuments.in/reader038/viewer/2022110400/56649daa5503460f94a98619/html5/thumbnails/15.jpg)
![Page 16: The Vexing Problem of Vasoplegia SCOTT SILVESTRY MD FLORIDA HOSPITAL TRANSPLANT INSTITUTE.](https://reader038.fdocuments.in/reader038/viewer/2022110400/56649daa5503460f94a98619/html5/thumbnails/16.jpg)
![Page 17: The Vexing Problem of Vasoplegia SCOTT SILVESTRY MD FLORIDA HOSPITAL TRANSPLANT INSTITUTE.](https://reader038.fdocuments.in/reader038/viewer/2022110400/56649daa5503460f94a98619/html5/thumbnails/17.jpg)
Prophylactic Vasopressin in Patients Receiving the Angiotensin-ConvertingEnzyme Inhibitor Ramipril Undergoing Coronary Artery Bypass Graft Surgery
A (n 16), patients discontinued ramipril 24 hours before surgery;B (n 16), patients continued ramipril until the morning of surgery; C (n 15), patients continued ramipril until the morning of surgery and received vasopressin infusion (0.03 U/min) from the onset ofrewarming
Journal of Cardiothoracic and Vascular Anesthesia, Vol 24, No 2 (April), 2010: pp 230-238
![Page 18: The Vexing Problem of Vasoplegia SCOTT SILVESTRY MD FLORIDA HOSPITAL TRANSPLANT INSTITUTE.](https://reader038.fdocuments.in/reader038/viewer/2022110400/56649daa5503460f94a98619/html5/thumbnails/18.jpg)
Preoperative Methylene Blue Administration in Patients at High Risk for Vasoplegic Syndrome During Cardiac Surgery
Ozal et al ATS 79(5)1615-1619 2005.
One hundred patients scheduled for coronary artery bypass graft surgery who were at high risk for vasoplegia because they were preoperatively using angiotensin-converting enzyme inhibitors, calcium channel blockers, and heparin were randomly assigned to either receive preoperative methylene blue (group 1, n = 50) or not receive it (group 2, controls, n = 50). Methylene blue (1% solution) was administered intravenously at a dose of 2 mg/kg for more than 30 minutes, beginning in the intensive care unit 1 hour before surgery.
![Page 19: The Vexing Problem of Vasoplegia SCOTT SILVESTRY MD FLORIDA HOSPITAL TRANSPLANT INSTITUTE.](https://reader038.fdocuments.in/reader038/viewer/2022110400/56649daa5503460f94a98619/html5/thumbnails/19.jpg)
![Page 20: The Vexing Problem of Vasoplegia SCOTT SILVESTRY MD FLORIDA HOSPITAL TRANSPLANT INSTITUTE.](https://reader038.fdocuments.in/reader038/viewer/2022110400/56649daa5503460f94a98619/html5/thumbnails/20.jpg)
![Page 21: The Vexing Problem of Vasoplegia SCOTT SILVESTRY MD FLORIDA HOSPITAL TRANSPLANT INSTITUTE.](https://reader038.fdocuments.in/reader038/viewer/2022110400/56649daa5503460f94a98619/html5/thumbnails/21.jpg)
Early vasopressor use Vasopressin: Infusion rates up to 0.06 units/min (maximum) – first line agentNorepinephrine: Infusion rates starting at 0.05 mcg/kg/min – second line agent, as these patients may be refractory to refractory catecholamines.
Other suggested treatments Methylene blue: 2 mg/kg IV
Correct underlying causes for a metabolic acidosis
Resuscitation goals
Target MAP between 70-80 Intravascular volume expansion – careful administration to avoid excessive volume loading
![Page 22: The Vexing Problem of Vasoplegia SCOTT SILVESTRY MD FLORIDA HOSPITAL TRANSPLANT INSTITUTE.](https://reader038.fdocuments.in/reader038/viewer/2022110400/56649daa5503460f94a98619/html5/thumbnails/22.jpg)
![Page 23: The Vexing Problem of Vasoplegia SCOTT SILVESTRY MD FLORIDA HOSPITAL TRANSPLANT INSTITUTE.](https://reader038.fdocuments.in/reader038/viewer/2022110400/56649daa5503460f94a98619/html5/thumbnails/23.jpg)
Statement 6: (grade C, level 2)In patients with vasodilatory shock requiring vasopressor support and with low filling pressures methylene blue may reduce the duration of the vasoplegic syndrome and the need for norepinephrine infusion.
Methylene blue may also reduce mortality and morbidity in these patients.
Statement 7: (grade C, level 2)Prophylactic use of methylene blue may reduce postoperative CPB hypotension and vasopressor requirements. Methylene blue in this setting may also be associated with shorter length of stay in the ICU.
Statement 8: (grade C, level 2)Prophylactic use of vasopressin reduces postoperative CPB hypotension and vasopressor requirements. Vasopressin in this setting may also be associated with shorter intubation time and length of stay in the ICU.
![Page 24: The Vexing Problem of Vasoplegia SCOTT SILVESTRY MD FLORIDA HOSPITAL TRANSPLANT INSTITUTE.](https://reader038.fdocuments.in/reader038/viewer/2022110400/56649daa5503460f94a98619/html5/thumbnails/24.jpg)
Role of EMCO/MCS ?LVAD/BIVADCase Reports
1 LVAD
BiVAD
ECMOTreated 2 patients post OHT
Normal Graft function/profound hypotension
Profound Acidosis
36 hrs ECMO
Flows 6-8 liters
Resolution of acidosis/hypotension
Both survived with normal function
![Page 25: The Vexing Problem of Vasoplegia SCOTT SILVESTRY MD FLORIDA HOSPITAL TRANSPLANT INSTITUTE.](https://reader038.fdocuments.in/reader038/viewer/2022110400/56649daa5503460f94a98619/html5/thumbnails/25.jpg)
Summary
Vasoplegia remains hard to predict and devastating in its impact.
Consider Discontinuing ACEi prior to cardiac surgery.
Consider prophylactic Vasopression/MB in high risk candidates.
Consider escalation of MCS ( ECMO/RVAD) in appropriate scenarios (LVAD, Heart transplant).
![Page 26: The Vexing Problem of Vasoplegia SCOTT SILVESTRY MD FLORIDA HOSPITAL TRANSPLANT INSTITUTE.](https://reader038.fdocuments.in/reader038/viewer/2022110400/56649daa5503460f94a98619/html5/thumbnails/26.jpg)
Thank you